Nootropics Depot Sponsors Future Nutra Innovation Summit

TEMPE, Ariz., Sept. 10, 2026 /PRNewswire/ -- Nootropics Depot will serve as a headline sponsor of the Future Nutra Innovation Summit, or FNIS, taking place Sept. 9-11, 2026, at Margaritaville Lake Resort on Lake Conroe, Texas. Members of the ND team will deliver three educational presentations centered on analytical rigor, transparent quality standards, and the role of science in strengthening the dietary supplement industry.

The Future Nutra Innovation Summit gathers together experts, researchers, manufacturers, ingredient suppliers and industry leaders with a shared objective: advancing more credible, evidence-based nutrition and supplement practices. Produced by the Future Nutra Foundation, a 501(c)(3) nonprofit, FNIS emphasizes stronger ingredient standards, transparent verification and collaborative action to move the industry forward.

As a headline sponsor, Nootropics Depot will contribute to the conversation through three sessions focused on practical ways the industry can raise its standards. The company's programming will address the need for validated analytical methods, meaningful product specifications, and greater accountability for the compounds that give botanical products their intended effects.

Nootropics Depot President and CEO Paul Eftang will deliver a main-stage keynote, "The Bioactive Imperative". This presentation will examine why botanical quality cannot be established through plant identity testing or marketing-oriented extract ratios alone, and why manufacturers should quantify the specific, pharmacologically relevant bioactive compounds associated with a product's intended effects.

"An industry that wants consumer trust cannot simply talk about quality. It has to demonstrate it with evidence," Eftang said. "That means putting real specifications behind the label, using the analytical tools needed to verify them and being willing to share what the data shows. We have an opportunity to raise the standard from whether a product merely contains a botanical to whether it contains the bioactive compounds that result in the benefits consumers and researchers expect."

Eftang's keynote draws on Nootropics Depot's work in analytical testing and its position that standards should be grounded in the compounds that matter, rather than unverifiable claims. For botanicals, that approach means connecting published research, finished-product specifications and batch-level analytical verification in a way that supports reproducibility, transparency and informed purchasing decisions.

"Nootropics Depot is proud to support Future Nutra's mission, but sponsorship alone is not enough," Eftang said. "We are calling on brands, suppliers, laboratories and industry organizations to contribute to higher standards together. The future of this industry depends on choosing science over marketing and transparency over ambiguity."

The two additional presentations from Nootropics Depot team members will address related themes of analytical verification, product integrity, and practical pathways for raising supplement-industry standards. Together, the sessions are intended to contribute useful technical perspectives to the broader work of the Future Nutra Foundation and the professionals participating in FNIS.

Matt Harrier, executive director of Future Nutra, will present on why the foundation exists, its long-term vision for the industry and the role of fundraising in supporting that work. "Future Nutra exists because meaningful progress requires a shared commitment to better science, better transparency and better accountability," Harrier said. "FNIS creates space for the people shaping this industry to move beyond discussion and support the work required to build a more credible future."

Nootropics Depot encourages other manufacturers, laboratories, suppliers, and industry organizations to support the Future Nutra Foundation's mission. Progress will require sustained cooperation across the supply chain, including investment in research, transparent testing practices, education and independent initiatives that strengthen consumer confidence.

About Nootropics Depot

Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded in 2013, Nootropics Depot's mission has been to educate consumers on the science behind dietary supplements, and to advance the lab testing and quality control standards of the industry. Their stance is that consumers should be able to trust the products they buy, and that the brands selling those products have a duty to ensure they are using modern validated science. Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements. The company's commitment to quality and transparency is evident in their rigorous testing procedures, easily accessible Certificates of Analysis (COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned website features a user-friendly interface, and includes an innovative quiz to help beginners find the right supplements for their needs. With partnerships with third-party labs, and collaboration with the Future Nutra Foundation, Nootropics Depot continues to push the boundaries of supplement quality and consumer education. For more information about Nootropics Depot's products and their commitment to transparency, visit nootropicsdepot.com.

Media Contact:
Michael Packman
Nootropics Depot
[email protected]

SOURCE Nootropics Depot